Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Zen Rating
Financials
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
MOH
MOLINA HEALTHCARE INC
$9.23B20.10%5.50%16.10%26.30%2.751.6810.10%2.00%2.97%
OLMA
OLEMA PHARMACEUTICALS INC
$1.77B-41.50%-37.60%-48.25%-50.60%0.158.03N/AN/AN/A
VSTM
VERASTEM INC
$407.33MN/A-159.10%-204.07%-526.30%-12.392.5882.00%-1,802.10%-1,786.77%
BTAI
BIOXCEL THERAPEUTICS INC
$34.77MN/A-185.00%-738.28%-61.10%-1.501.18-28.20%-9,070.60%-6,860.51%
ENGN
ENGENE HOLDINGS INC
$638.36M-55.50%-46.00%-60.32%-54.00%0.326.30N/AN/AN/A
MAIA
MAIA BIOTECHNOLOGY INC
$89.25M-715.10%-199.20%-1,249.70%434.20%281.751.18N/AN/AN/A
PHIO
PHIO PHARMACEUTICALS CORP
$10.87M-86.40%-75.80%-80.83%960.20%0.176.90N/AN/AN/A
VTGN
VISTAGEN THERAPEUTICS INC
$22.12M-90.70%-76.20%-92.50%-747.70%0.225.79100.00%-8,631.90%-8,631.90%
NNOX
NANO-X IMAGING LTD
$178.54M-32.50%-29.00%-35.30%-75.50%0.124.14-98.00%-452.80%-469.77%
ASBP
ASPIRE BIOPHARMA HOLDINGS INC
$5.72MN/A-1,490.10%158.11%923.80%-1.210.1745.50%-1,056,755.00%-933,320.14%
IMUX
IMMUNIC INC
$75.18M-716.20%-252.10%-969.85%507.30%2.881.31N/AN/AN/A
CMND
CLEARMIND MEDICINE INC
$3.25M-208.10%-70.70%-317.50%172.70%4.101.22N/AN/AN/A
ENTX
ENTERA BIO LTD
$62.82M-71.90%-63.40%-67.99%2,206.40%0.1410.830.00%-8,694.40%-8,683.06%
GNPX
GENPREX INC
$6.04M-891.70%-389.10%-1,658.99%-18,136.00%3.640.67N/AN/AN/A
OMER
OMEROS CORP
$828.83MN/A-53.90%-121.65%-23.80%-1.840.89N/AN/AN/A
QNRX
QUOIN PHARMACEUTICALS LTD
$10.59M-334.40%-125.20%-2,088.80%-453.90%-6.291.04N/AN/AN/A
RYTM
RHYTHM PHARMACEUTICALS INC
$6.84B-445.30%-47.70%-42.34%-84.70%1.424.7589.40%-113.40%-97.79%
IRON
DISC MEDICINE INC
$2.92B-31.60%-29.00%-29.38%-36.40%0.1023.45N/AN/AN/A
LEXX
LEXARIA BIOSCIENCE CORP
$19.51M-209.60%-168.30%-234.89%-4,098.00%0.313.68100.00%-2,067.70%-2,067.31%
AARD
AARDVARK THERAPEUTICS INC
$282.83M-54.90%-37.90%-39.82%-58.70%0.0912.04N/AN/AN/A
ACLX
ARCELLX INC
$3.95B-51.10%-33.10%-46.45%-49.00%0.493.99100.00%-607.00%-695.50%
RNTX
REIN THERAPEUTICS INC
$34.17M-118.70%-102.00%-125.99%1,317.70%0.160.90N/AN/AN/A
OSRH
OSR HOLDINGS INC
$14.99MN/AN/AN/AN/A0.530.21N/AN/AN/A
VVOS
VIVOS THERAPEUTICS INC
$14.56M-351.30%-87.40%-93.94%-180.60%9.130.7855.70%-98.80%-98.77%
IKT
INHIBIKASE THERAPEUTICS INC
$112.76M-57.20%-52.80%-65.37%-217.00%0.0911.73N/AN/AN/A
GANX
GAIN THERAPEUTICS INC
$64.98M-341.30%-174.10%-266.08%1,085.50%0.862.52N/AN/AN/A
ABEO
ABEONA THERAPEUTICS INC
$275.83M78.40%48.00%41.45%86.10%0.359.74-22.00%20,587.50%21,650.75%
INO
INOVIO PHARMACEUTICALS INC
$87.32M-307.60%-127.90%24,665.13%-846.50%-9.990.79100.00%-59,281.70%-59,281.69%
EVH
EVOLENT HEALTH INC
$358.24M-19.70%-7.20%-5.62%-13.50%1.911.3318.40%-8.80%-5.54%
ELAB
PMGC HOLDINGS INC
$652.97k-82.90%-63.50%-70.06%-523.90%0.761.7982.20%458.40%454.25%
CLNN
CLENE INC
$42.27MN/A-125.60%-200.24%-105.20%-2.811.5382.20%-14,250.50%-13,104.67%
LFMD
LIFEMD INC
$155.96MN/A-10.80%-22.51%11.70%47.640.7387.00%-3.10%-0.83%
BCAX
BICARA THERAPEUTICS INC
$920.34M-27.20%-26.00%-30.02%-205.00%0.0514.14N/AN/AN/A
IMVT
IMMUNOVANT INC
$4.56B-84.90%-76.10%-88.98%8,805.10%0.129.07N/AN/AN/A
SRRK
SCHOLAR ROCK HOLDING CORP
$4.52B-122.00%-86.50%-100.33%-144.60%0.686.31N/AN/AN/A
IOVA
IOVANCE BIOTHERAPEUTICS INC
$1.01B-55.20%-43.10%-51.12%-96.30%0.293.4124.00%-158.80%-159.06%
NRIX
NURIX THERAPEUTICS INC
$1.70B-57.50%-43.80%-43.83%-59.10%0.287.02100.00%-314.90%-314.00%
DTIL
PRECISION BIOSCIENCES INC
$52.50M-213.80%-72.20%-104.61%-207.20%4.623.45100.00%-11,977.40%-11,767.34%
AVIR
ATEA PHARMACEUTICALS INC
$331.26M-38.40%-35.90%-45.29%-48.10%0.0916.66N/AN/AN/A
ARMP
ARMATA PHARMACEUTICALS INC
$243.41MN/A-54.50%63.18%-29.50%-1.940.12100.00%-3,797.70%-2,580.16%
LAB
STANDARD BIOTOOLS INC
$538.39M-29.30%-22.40%-29.33%-42.40%0.354.3847.90%-99.60%-98.29%
ORIC
ORIC PHARMACEUTICALS INC
$999.21M-45.30%-41.80%-32.91%-55.20%0.0614.65N/AN/AN/A
AGIO
AGIOS PHARMACEUTICALS INC
$1.60B-28.40%-26.40%-31.29%-28.90%0.0813.8287.20%-895.90%-915.68%
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$3.24M-476.10%-253.90%-674.65%-20,966.60%1.541.66N/AN/AN/A
VIR
VIR BIOTECHNOLOGY INC
$1.04B-50.80%-40.60%-52.89%-55.50%0.287.2595.90%-2,963.50%-2,961.95%
CYTK
CYTOKINETICS INC
$7.73BN/A-56.50%-54.98%-36.10%-3.766.88100.00%-862.20%-816.07%
IFRX
INFLARX NV
$59.75M-68.50%-53.20%-86.90%-104.20%0.443.33-8,223.10%-63,818.90%-63,757.59%
NMRA
NEUMORA THERAPEUTICS INC
$332.51M-113.80%-96.90%-154.89%-242.80%0.356.85N/AN/AN/A
STEX
STREAMEX CORP
$141.56MN/A-65.00%-826.64%68.50%-19.740.12100.00%-306,861.50%-312,469.23%
TRAW
TRAWS PHARMA INC
$16.86M-2,912.00%518.00%2,048.95%-1,528.40%1.741.22100.00%3,280.00%3,280.04%
OSUR
ORASURE TECHNOLOGIES INC
$200.14M-15.60%-13.30%-15.12%-44.50%0.177.0340.40%-47.90%-46.05%
BMEA
BIOMEA FUSION INC
$79.19M-310.10%-145.40%-241.56%-1,835.00%2.533.18N/AN/AN/A
DNTH
DIANTHUS THERAPEUTICS INC
$2.29B-33.00%-31.10%-22.82%-34.90%0.0617.35100.00%-4,104.80%-4,104.78%
VANI
VIVANI MEDICAL INC
$101.40M-293.60%-79.50%-142.87%-80.80%18.130.61N/AN/AN/A
GTBP
GT BIOPHARMA INC
$7.02M-1,161.90%-203.50%-303.27%392.30%0.443.27N/AN/AN/A
BBNX
BETA BIONICS INC
$608.86M-46.80%-27.10%-25.55%-32.90%0.1210.6454.50%-87.90%-87.89%
RCKT
ROCKET PHARMACEUTICALS INC
$376.61M-62.40%-53.90%-70.95%-83.00%0.177.30N/AN/AN/A
SGMT
SAGIMET BIOSCIENCES INC
$184.40M-42.40%-40.30%-48.36%-70.10%0.0813.06N/AN/AN/A
ACET
ADICET BIO INC
$76.53M-77.90%-64.30%-94.62%-84.00%0.295.62N/AN/AN/A
SLDB
SOLID BIOSCIENCES INC
$503.30M-73.60%-60.00%-70.12%-112.70%0.266.74N/AN/AN/A
VERA
VERA THERAPEUTICS INC
$2.77B-50.90%-42.70%-51.39%-43.50%0.3012.21N/AN/AN/A
DCGO
DOCGO INC
$75.02M-17.20%-12.50%-25.25%-36.70%0.342.5931.20%-14.00%-19.22%
PMVP
PMV PHARMACEUTICALS INC
$57.47M-55.30%-51.00%-69.86%-78.60%0.1110.77N/AN/AN/A
NVCT
NUVECTIS PHARMA INC
$207.74M-155.40%-99.90%-115.81%284.60%0.483.07N/AN/AN/A
SNDA
SONIDA SENIOR LIVING INC
$597.82M-96.10%-6.20%-1.06%-0.60%25.810.7021.50%-13.90%-2.13%
ELUT
ELUTIA INC
$44.84MN/A-76.40%197.10%-150.20%-1.670.4546.00%-125.60%-111.50%
ACHV
ACHIEVE LIFE SCIENCES INC
$222.52M-196.70%-118.30%-121.91%-306.00%0.555.14N/AN/AN/A
EYPT
EYEPOINT PHARMACEUTICALS INC
$1.12B-76.10%-61.70%-92.76%-87.80%0.267.1894.10%-486.00%-485.49%
WHWK
WHITEHAWK THERAPEUTICS INC
$127.25M-10.40%-9.60%-9.94%-37.60%0.0616.7689.20%-108.60%-108.58%
KOD
KODIAK SCIENCES INC
$1.21B-246.20%-78.40%-123.74%-76.50%8.201.79N/AN/AN/A
AVBP
ARRIVENT BIOPHARMA INC
$928.42M-59.70%-55.70%-49.64%-90.90%0.0714.90N/AN/AN/A
XENE
XENON PHARMACEUTICALS INC
$3.17B-46.20%-43.40%-54.38%-55.80%0.0912.53100.00%-4,084.50%-4,129.39%
TECX
TECTONIC THERAPEUTIC INC
$374.14M-27.10%-25.90%-24.75%9,383.70%0.0429.15N/AN/AN/A
GRI
GRI BIO INC
$4.71M-381.70%-206.40%-198.51%624.90%0.443.25N/AN/AN/A
CRDF
CARDIFF ONCOLOGY INC
$117.88M-77.20%-62.80%-102.75%-117.30%0.314.20100.00%-10,069.10%-10,064.27%
ELDN
ELEDON PHARMACEUTICALS INC
$131.85M-94.90%-49.30%-65.03%-56.80%1.106.74N/AN/AN/A
SMMT
SUMMIT THERAPEUTICS INC
$10.78B-311.20%-262.40%-463.89%-997.70%0.363.80N/AN/AN/A
DFTX
DEFINIUM THERAPEUTICS INC
$1.66B-86.20%-62.30%-95.18%-120.30%0.813.30N/AN/AN/A
ONCY
ONCOLYTICS BIOTECH INC
$101.67M-755.20%-188.30%-478.42%2,290.60%129.931.84N/AN/AN/A
PCVX
VAXCYTE INC
$7.01B-21.10%-19.70%-22.12%-22.30%0.108.83N/AN/AN/A
CABA
CABALETTA BIO INC
$247.40M-107.10%-82.90%-108.54%-298.40%0.363.60N/AN/AN/A
PHGE
BIOMX INC
$8.73M-68.40%-35.00%-51.75%-43.60%1.501.70N/AN/AN/A
PRME
PRIME MEDICINE INC
$687.75M-163.50%-61.20%-56.38%-72.20%1.386.61100.00%-3,301.60%-3,301.64%
MGTX
MEIRAGTX HOLDINGS PLC
$612.54M-1,065.50%-76.50%-427.19%-93.50%-5.670.2241.00%-615.30%-569.48%
AVTX
AVALO THERAPEUTICS INC
$274.00M-88.40%-73.90%-86.18%-288.20%0.3714.2854.70%-52,019.80%-52,575.52%
BHVN
BIOHAVEN LTD
$1.25B-389.90%-153.40%-263.08%-206.40%-24.842.86N/AN/AN/A
BCTX
BRIACELL THERAPEUTICS CORP
$8.10M-277.90%-190.40%-299.07%-911.50%0.403.42N/AN/AN/A
SNGX
SOLIGENIX INC
$12.61M-267.10%-135.70%-149.12%441.10%0.493.18N/AN/AN/A
CING
CINGULATE INC
$38.79M-394.50%-172.00%-475.88%-694.30%2.031.26N/AN/AN/A
VKTX
VIKING THERAPEUTICS INC
$3.28B-29.30%-28.40%-33.28%-31.20%0.0428.34N/AN/AN/A
MYO
MYOMO INC
$32.25M-61.10%-30.80%-46.25%-56.30%1.332.4966.60%-28.90%-27.63%
CDXS
CODEXIS INC
$112.00M-121.40%-47.40%-53.78%-37.00%2.224.1279.30%-120.80%-107.17%
KALA
KALA BIO INC
$4.35M-2,323.90%-87.00%414.59%-230.60%-3.890.75N/AN/AN/A
MGNX
MACROGENICS INC
$115.76M-98.30%-30.30%-31.21%-50.60%3.045.2275.40%-59.50%-55.34%
REPL
REPLIMUNE GROUP INC
$551.46M-82.80%-61.60%-89.68%-75.20%0.486.31N/AN/AN/A
RZLT
REZOLUTE INC
$309.71M-62.80%-57.10%-51.99%-81.70%0.0815.15N/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$83.17M-218.50%-154.20%-360.16%733.30%0.353.89N/AN/AN/A
AVR
ANTERIS TECHNOLOGIES GLOBAL CORP
$245.95M-251.50%-170.00%-1,492.94%4,106.10%4.250.8467.90%-3,941.70%-3,938.38%
ATOS
ATOSSA THERAPEUTICS INC
$72.98M-49.40%-44.80%-60.62%5,857.40%0.176.77N/AN/AN/A
ABSI
ABSCI CORP
$449.61M-60.20%-50.90%-52.98%-103.30%0.175.89100.00%-4,071.20%-4,051.97%

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
609-1.38%-2.24%-0.64%-34.66%168.05x5.44x-21.13%-8.36%-3.73%+67.22%Strong Buy
56-1.08%-3.30%+0.77%+10.80%21.89x4.45x-0.87%+6.07%+13.04%+10.05%Strong Buy
20+0.91%-0.14%+0.75%+24.88%44.57x7.09x+103.29%+12.26%+20.35%+5.39%Buy
77-0.31%-0.78%-0.10%-5.30%-89.14x1.68x+9.15%+2.77%+5.97%+47.52%Buy
10-0.78%-12.61%-6.85%-27.93%40.31x1.90x+11.85%+3.67%+9.04%+23.19%Buy
54-1.30%-5.97%-11.09%-28.74%28.48x3.58x+8.80%+4.64%+7.67%+47.30%Buy
50+0.65%-1.56%-1.62%-61.28%14.81x5.27x-84.47%+7.37%+16.25%+22.71%Buy
139+0.49%-1.31%-0.22%-84.97%24.69x3.81x+11.43%+6.89%+8.29%+37.73%Strong Buy
10+1.41%+1.48%+2.03%+36.23%32.67x3,682.50x-53.57%+3.44%+21.75%+7.47%Strong Buy
57-0.41%-2.30%-5.46%-22.90%200.91x3.12x+9.80%+8.40%+10.96%+23.23%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top healthcare stock out of 1082 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: A, Sentiment: A, Safety: C, Financials: A, and AI: C.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 40, which is 14 points higher than the healthcare sector average of 26. It passed 13 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 112.61% over the past year, overperforming other healthcare stocks by 162 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $6.50, an upside of 32.92% from Ironwood Pharmaceuticals's current stock price of $4.89.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Varex Imaging (NASDAQ:VREX)


Varex Imaging (NASDAQ:VREX) is the #2 top healthcare stock out of 1082 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Varex Imaging (NASDAQ:VREX) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Varex Imaging (NASDAQ:VREX) has a Due Diligence Score of 20, which is -6 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates VREX as a "A".It passed 6 out of 33 due diligence checks and has weak fundamentals. Varex Imaging has seen its stock lose -0.36% over the past year, overperforming other healthcare stocks by 49 percentage points.

Varex Imaging has an average 1 year price target of $16.67, an upside of 19.56% from Varex Imaging's current stock price of $13.94.

Varex Imaging stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Varex Imaging, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Tactile Systems Technology (NASDAQ:TCMD)


Tactile Systems Technology (NASDAQ:TCMD) is the #3 top healthcare stock out of 1082 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Tactile Systems Technology (NASDAQ:TCMD) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Tactile Systems Technology (NASDAQ:TCMD) has a Due Diligence Score of 50, which is 24 points higher than the healthcare sector average of 26. It passed 16 out of 33 due diligence checks and has strong fundamentals. Tactile Systems Technology has seen its stock return 60.69% over the past year, overperforming other healthcare stocks by 110 percentage points.

Tactile Systems Technology has an average 1 year price target of $27.00, a downside of -6.44% from Tactile Systems Technology's current stock price of $28.86.

Tactile Systems Technology stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Tactile Systems Technology, 75% have issued a Strong Buy rating, 0% have issued a Buy, 25% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 68 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 25.19%, which is 23 percentage points higher than the healthcare sector average of 2.2%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.08%, which is 7 percentage points higher than the healthcare sector average of 2.2%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)


Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.42%, which is 5 percentage points higher than the healthcare sector average of 2.2%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.56% in the last day, and down -2.51% over the last week. China Sxt Pharmaceuticals was the among the top losers in the healthcare sector, dropping -38% yesterday.

China SXT Pharmaceuticals shares are trading lower after the company announced a 1-for-150 reverse stock split.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -7.64% in the past year. It has overperformed other stocks in the healthcare sector by 42 percentage points.

2. Bausch Health Companies (NYSE:BHC)


Bausch Health Companies (NYSE:BHC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -23.06% in the past year. It has overperformed other stocks in the healthcare sector by 26 percentage points.

3. Organon & Co (NYSE:OGN)


Organon & Co (NYSE:OGN) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -46.52% in the past year. It has overperformed other stocks in the healthcare sector by 3 percentage points.

Are healthcare stocks a good buy now?

57.76% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 37.41% over the next year.

8.1% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.5% of healthcare stocks are rated B (Buy), 46.07% are rated C (Hold), 25.24% are rated D (Sell), and 8.1% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 61.49x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.